Home 
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.9, p.635–638, 2023
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.9, p.635–638, 2023
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.124, No.9, p.635–638, 2023 |
||
| Title: Surgery for cardiac myxomas: 12-year experience | ||
| Author: Ivo GASPAROVIC, Panagiotis ARTEMIOU, Branislav BEZAK, Stefan MICHUT, Michal HULMAN | ||
| Abstract: INTRODUCTION: Cardiac myxoma is a rare benign cardiac tumor observed in approximately 0.5–1 case per 1 million people per year. The aim of this study is to review our 12-year experience in the surgical treatment of cardiac myxoma with an emphasis on the clinical, pathologic, diagnostic, and surgical features. METHODS AND PATIENTS: From January 2010 to December 2022, 90 patients (0.67 %) with cardiac myxomas were surgically treated in our institute. Patients´ demographics, cardiac and surgical medical history, surgical procedures, and pre- and post-operative data were analyzed. The median follow-up time was 76 (1–216) months. RESULTS: The mean age of the patients was 59.4 ± 13.5 years, with a higher prevalence of women. The most common preoperative symptoms were arterial embolism and dyspnea, and 35.6 % of patients were asymptomatic. Only 8.9 % of the patients had systemic and constitutional manifestations. The most common location of cardiac myxoma was in the left atrium, followed by the right atrium. Recurrent myxoma developed in 3 patients (2.7 %), and the mean time of recurrence was 55 ± 19.7. Hospital and long-term mortality were 2.2 % and 15.6 %, respectively. CONCLUSION: Cardiac myxoma is the most common heart tumor with a low incidence. Surgical excision yields very good short and long-term outcomes with low recurrence rate after surgery, and remains the treatment of choice (Tab. 4, Fig. 2, Ref. 13). Text in PDF www.elis.sk |
||
| Keywords: cardiac myxoma, cardiac tumor, recurrence, survival | ||
| Published online: 04-Jul-2023 | ||
| Year: 2023, Volume: 124, Issue: 9 | Page From: 635, Page To: 638 | |
| doi:10.4149/BLL_2023_098 |
||
|
|
 download file |
|